Literature DB >> 3711868

Rapid diagnosis of echovirus 33 infection by neutralizing specific IgM antibody.

B Pozzetto, J C Le Bihan, O G Gaudin.   

Abstract

In 1982, we isolated 20 strains of echovirus type 33 (EV33) from 18 patients. We studied the humoral response to EV33 of 2,437 subjects from whom at least one serum was available during the same year. In 388 subjects with the neutralizing antibody level at 64 or more, we assayed the EV33 IgM antibodies by seroneutralization test after fractionation of sera by ion exchange chromatography. One hundred ninety-five subjects (8.0%) had a high titre (greater than or equal to 32) of EV33 IgM antibodies, which was considered as evidence of recent infection. The EV33-positive IgM fractions were assayed against five other enteroviruses. Sixty percent of the IgM fractions did not cross-react with any of the five serotypes, 8.7% cross-reacted with at least one serotype but with predominant EV33 IgM response, and 31.3% had an equivalent or greater amount of non-EV33 IgM antibodies; the type specificity of the assay was directly related to the age of the subjects. These findings suggest that determination of neutralizing specific IgM antibody is a sensitive and rapid test for the diagnosis of enterovirus infections, especially in young people.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711868     DOI: 10.1002/jmv.1890180409

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Detection of antibodies against initial polypeptides in patients infected with an enterovirus (EV-33).

Authors:  M Aouni; O Gaudin; B Pozzetto; J C le Bihan
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Comparative evaluation of immunoglobulin M neutralizing antibody response in acute-phase sera and virus isolation for the routine diagnosis of enterovirus infection.

Authors:  B Pozzetto; O G Gaudin; M Aouni; A Ros
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.